Algert Global LLC 10x Genomics, Inc. Transaction History

Algert Global LLC

$4.77 Billion
Q2 2025

A detailed history of Algert Global LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 1,279,868 shares of TXG stock, worth $14.8 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

1,279,868

Previous 453,287 182.35%

Holding current value

$14.8 Million

Previous $3.96 Million 274.55%

% of portfolio

0.31%

Previous 0.1%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$7.14 - $11.73 $5.9 Million - $9.7 Million	826,581 Added 182.35%	1,279,868 $14.8 Million
Q1 2025 May 13, 2025	SELL	$8.73 - $16.31 $1.81 Million - $3.38 Million	-207,333 Reduced 31.38%	453,287 $3.96 Million
Q4 2024 Feb 14, 2025	BUY	$13.18 - $21.31 $3.82 Million - $6.17 Million	289,662 Added 78.08%	660,620 $9.49 Million
Q3 2024 Nov 12, 2024	BUY	$15.71 - $23.49 $3.97 Million - $5.94 Million	252,994 Added 214.47%	370,958 $8.38 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $648,929 - $1.25 Million	33,364 Added 39.44%	117,964 $2.29 Million
Q1 2024 May 14, 2024	BUY	$36.08 - $54.3 $2.14 Million - $3.22 Million	59,360 Added 235.18%	84,600 $3.18 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $166,452 - $279,117	4,850 Added 23.79%	25,240 $1.41 Million
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $887,520 - $1.37 Million	-21,721 Reduced 51.58%	20,390 $841,000
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $460,831 - $531,004	-9,043 Reduced 17.68%	42,111 $2.35 Million
Q1 2023 May 12, 2023	BUY	$35.33 - $55.79 $1.81 Million - $2.85 Million	51,154 New	51,154 $2.85 Million

Others Institutions Holding TXG

# of Institutions

334

Shares Held

116M

Call Options Held

442K

Put Options Held

149K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.1B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC 10x Genomics, Inc. Transaction History